1. Home
  2. MBAI vs CNSP Comparison

MBAI vs CNSP Comparison

Compare MBAI & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$4.02

Market Cap

8.9M

Sector

N/A

ML Signal

N/A

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

N/A

Current Price

$5.11

Market Cap

8.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MBAI
CNSP
Founded
2004
2017
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
8.5M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
MBAI
CNSP
Price
$4.02
$5.11
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $20.00
AVG Volume (30 Days)
★ 26.3K
3.8K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 8.03
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.95
$1.90
52 Week High
$10.21
$10.59

Technical Indicators

Market Signals
Indicator
MBAI
CNSP
Relative Strength Index (RSI) 31.55 42.10
Support Level $1.19 $4.64
Resistance Level $6.80 $5.53
Average True Range (ATR) 0.42 0.13
MACD -0.39 -0.07
Stochastic Oscillator 8.66 17.74

Price Performance

Historical Comparison
MBAI
CNSP

About MBAI Check-Cap Ltd. Ordinary Share

MBody AI Ltd is an embodied artificial intelligence company. Its core technology is the MBody AI Orchestrator (Orchestrator), a proprietary, hardware-agnostic software platform that serves as an intelligence layer designed to enable autonomous systems to operate, coordinate, and improve more effectively. MBody AI does not manufacture robots; it makes third-party robots more intelligent and coordinated through the Orchestrator and deploys them at customer sites together with its software and related services. Each deployment is designed to generate proprietary operational data. Its initial commercial focus is the hospitality industry, with potential applications across other labor-intensive sectors, including warehousing, office management, and healthcare.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Share on Social Networks: